Related references
Note: Only part of the references are listed.The epidermal growth factor network: role in oocyte growth, maturation and developmental competence
Dulama Richani et al.
HUMAN REPRODUCTION UPDATE (2018)
Arsenic Attenuates Heparin-Binding EGF-Like Growth Factor/EGFR Signaling That Promotes Matrix Metalloprotease 9-Dependent Astrocyte Damage in the Developing Rat Brain
Rajesh Kushwaha et al.
TOXICOLOGICAL SCIENCES (2018)
Molecular mechanisms involved in epidermal growth factor receptor-mediated inhibition of dopamine D-3 receptor signaling
Ningning Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia
R. Balotsev et al.
EUROPEAN PSYCHIATRY (2017)
Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
Md Shaki Mostaid et al.
FRONTIERS IN PSYCHIATRY (2017)
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
Kohei Miyata et al.
ANTICANCER RESEARCH (2017)
The EGF receptor inhibits the signaling of dopamine D3 receptor through the phosphorylation of GRK2 on tyrosine residues
NingNing Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population: a Case-Control Study
Shitian Zhang et al.
CLINICAL LABORATORY (2017)
Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia
J. Li et al.
EUROPEAN PSYCHIATRY (2016)
Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index
Liina Haring et al.
SCHIZOPHRENIA RESEARCH (2015)
Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients
Jan Malte Bumb et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2015)
Prediction of Depression in Schizophrenia: Can serum Levels of BDNF or EGF Help us?
Ebru Oztepe Yavasci
African Journal of Psychiatry (2014)
Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales
I. Flisiak et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2014)
Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
Hiroyuki Nawa et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies
Jian-Min Yuan et al.
BMC GASTROENTEROLOGY (2013)
Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling
Hidekazu Sotoyama et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients
Maria Teresa Pellecchia et al.
JOURNAL OF NEUROLOGY (2013)
Electroconvulsive Therapy Improves Clinical Manifestation with Plasma BDNF Levels Unchanged in Treatment-Resistant Depression Patients
Ching-Hua Lin et al.
NEUROPSYCHOBIOLOGY (2013)
Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: Impact on dopamine metabolism
Takeyoshi Eda et al.
NEUROSCIENCE LETTERS (2013)
Serum EGF and NGF levels of patients with brain injury and limb fracture
Yan-Feng Zhuang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2013)
ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease
Yuriko Iwakura et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
Takefumi Suzuki et al.
PSYCHIATRY RESEARCH (2012)
Increased Serum Levels of Epidermal Growth Factor in Children with Autism
Elvan Iseri et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2011)
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia
Yumiko Ikeda et al.
SCHIZOPHRENIA RESEARCH (2008)
Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism
Katsuaki Suzuki et al.
BIOLOGICAL PSYCHIATRY (2007)
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Luisella Bocchio-Chiavetto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
No changes in serum epidermal growth factor levels in patients with schizophrenia
K Hashimoto et al.
PSYCHIATRY RESEARCH (2005)
Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients
T Futamura et al.
MOLECULAR PSYCHIATRY (2002)